NEW YORK (GenomeWeb News) – The bio-agricultural company Monsanto will use Cellectis' meganuclease genomic engineering technology under a new license agreement, Cellectis said today.

The Cellectis technology involves using "molecular scissors" that can locate a single site in the genome of a plant cell, allowing a range of precise genome modifications, such as gene stacking, gene knock-out, and modulation of gene function.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.